Tearlab Revenue Growth Rates (TEAR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Tearlab Corp  (TEAR)
 

TEAR's Revenue Growth by Quarter and Year

Tearlab's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TEAR Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 5.09
FY 5.09

TEARs Annual Revenue
Tearlab's Revenue in the fiscal year 2019 $ 22.66 millions
Tearlab's Revenue in the fiscal year 2018 $ 25.00 millions
Tearlab's Revenue in the fiscal year 2017 $ 27.12 millions
Tearlab's Revenue in the fiscal year 2016 $ 28.01 millions
Tearlab's Revenue in the fiscal year 2015 $ 25.16 millions




TEAR Revenue first quarter 2020 Y/Y Growth Comment
Tearlab Corp reported decrease in Revenue in the first quarter 2020 by -7.94% to $ 5.09 millions, from the same quarter in 2019.
The decrease in the first quarter 2020 Tearlab Corp's Revenue compares unfavorably to the Company's average Revenue jump of 52.65%.

Looking into first quarter 2020 results within Medical Equipment & Supplies industry 118 other companies have achieved higher Revenue growth. While Tearlab Corp' s Revenue decline of -7.94% ranks overall at the positon no. 2517 in the first quarter 2020.


TEAR Revenue ( Y/Y Growth %) 2020
 2019 2018 2017
4th Quarter December - -5.68 % -12.94 % -3.37 %
3rd Quarter September - -8.46 % -5.67 % -9.7 %
2nd Quarter June - -8.74 % -8.56 % 1.59 %
1st Quarter March -7.94 % -14.26 % -3.73 % -1.03 %
FY   - -9.36 % -7.78 % -

Financial Statements
Tearlab's first quarter 2020 Revenue $ 5.09 millions TEAR's Income Statement
Tearlab's first quarter 2019 Revenue $ 5.53 millions Quarterly TEAR's Income Statement


TEAR Revenue (Quarter on Quarter Growth %)

 2020
 2019 2018 2017
4th Quarter December - 0.36 % -2.6 % 5.52 %
3rd Quarter September - -3.76 % -4.06 % -6.99 %
2nd Quarter June - 5.79 % -0.62 % 4.63 %
1st Quarter March -9.89 % -7.68 % -6.25 % -5.9 %
FY (Year on Year)   - -9.36 % -7.78 % -


Back to TEAR Growth rate Comparisons >> Back to TEAR Growth rate Comparisons >>


Revenue first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #119
Healthcare Sector #391
Overall #2517

Revenue Y/Y Growth Statistics
High Average Low
486.49 % 52.65 % -14.21 %
(Mar 31 2013)   (Mar 31 2019)
Revenue first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #119
Healthcare Sector #391
Overall #2517
Revenue Y/Y Growth Statistics
High Average Low
486.49 % 52.65 % -14.21 %
(Mar 31 2013)   (Mar 31 2019)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Tearlab's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
69.67 % 9.75 % -9.83 %
(Jun 30 2012)   (Mar 31 2020)


TEAR's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2020 Tearlab Corp disclosed drop in Revenue from the fourth quarter by -9.89% to $ 5.09 millions, from $ 5.65 millions achived in the previous reporting period.

But that's not important problem, as Tearlab's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 81 other companies have achieved higher Revenue quarter on quarter growth. While Tearlab's Revenue growth quarter on quarter, overall rank is 2353.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #82
Healthcare Sector #323
Overall #2353
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #82
Healthcare Sector #323
Overall #2353
Revenue Q/Q Growth Statistics
High Average Low
69.67 % 9.75 % -9.83 %
(Jun 30 2012)   (Mar 31 2020)


TEAR's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2020 Tearlab Corp disclosed drop in Revenue from the fourth quarter by -9.89% to $ 5.09 millions, from $ 5.65 millions achived in the previous reporting period.

But that's not important problem, as Tearlab's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 81 other companies have achieved higher Revenue quarter on quarter growth. While Tearlab's Revenue growth quarter on quarter, overall rank is 2353.


Tearlab's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2020)		 12 Months Ending
(Dec 31 2019)		 12 Months Ending
(Sep 30 2019)		 12 Months Ending
(Jun 30 2019)		 12 Months Ending
(Mar 31 2019)
Cumulative Revenue 12 Months Ending $ 22.22 $ 22.66 $ 23.00 $ 23.52 $ 24.08
Y / Y Revenue Growth (TTM) -7.75 % -9.38 % -11.18 % -10.44 % -10.35 %
Year on Year Revenue Growth Overall Ranking # 2790 # 3184 # 1708 # 2630 # 2495
Seqeuential Revenue Change (TTM) -1.94 % -1.49 % -2.23 % -2.33 % -3.66 %
Seq. Revenue Growth (TTM) Overall Ranking # 2519 # 2880 # 1683 # 2583 # 2211


Cumulative Revenue growth Comment
Tearlab showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2019. If the fiscal year would end in Mar 31 2020, Tearlab's annual Revenue decline would be -7.75% year on year to $22 millions.

In the Healthcare sector 361 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2790, from total ranking in previous quarter at 3184.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 113
Healthcare Sector # 362
Overall # 2790

Revenue TTM Y/Y Growth Statistics
High Average Low
269.82 %
 28.59 %
-11.18 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 113
Sector # 402
S&P 500 # 2519
Cumulative Revenue growth Comment
Tearlab showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2019. If the fiscal year would end in Mar 31 2020, Tearlab's annual Revenue fall would be -7.75% year on year to $22 millions.

In the Healthcare sector 361 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2790, from total ranking in previous quarter at 3184.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 113
Healthcare Sector # 362
Overall # 2790

Revenue TTM Y/Y Growth Statistics
High Average Low
269.82 %
28.59 %
-11.18 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 113
Sector # 402
S&P 500 # 2519




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TEAR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2020
Regenerx Biopharmaceuticals inc -0.01%$ -0.005 millions
Seaspine Holdings Corporation-0.11%$ -0.108 millions
Bausch Health Companies Inc -0.20%$ -0.198 millions
Abiomed Inc -0.20%$ -0.204 millions
Lite Strategy Inc -0.40%$ -0.400 millions
Tenet Healthcare Corp-0.55%$ -0.550 millions
Pediatrix Medical Group Inc -0.62%$ -0.619 millions
Icu Medical Inc-0.70%$ -0.703 millions
Neos Therapeutics Inc -0.96%$ -0.964 millions
Hanger inc.-1.13%$ -1.134 millions
Atricure Inc -1.37%$ -1.373 millions
Integra Lifesciences Holdings Corp-1.49%$ -1.492 millions
United Therapeutics Corporation-1.74%$ -1.737 millions
Inogen Inc -1.90%$ -1.899 millions
Conmed Corporation-2.00%$ -2.000 millions
Invacare Holdings Corporation-2.23%$ -2.229 millions
Lifeloc Technologies Inc -2.44%$ -2.437 millions
Allied Healthcare Products inc -2.63%$ -2.631 millions
Fuse Medical Inc -2.81%$ -2.812 millions
U S Physical Therapy Inc-3.02%$ -3.023 millions
Icad Inc-3.19%$ -3.189 millions
Integrated Biopharma Inc-3.24%$ -3.244 millions
Livanova Plc-3.35%$ -3.351 millions
Cardiovascular Systems Inc -3.37%$ -3.374 millions
Sientra Inc -3.53%$ -3.532 millions
Accuray Incorporated-3.56%$ -3.558 millions
Quest Diagnostics Inc-3.65%$ -3.649 millions
Harrow Inc -3.85%$ -3.849 millions
Fonar Corporation-3.89%$ -3.891 millions
Nanostring Technologies Inc -3.91%$ -3.911 millions


About Tearlab Revenue Growth Rates (TEAR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.